International Clinical Trial: Comparing the Extent to Which Romosozumab (AMG 785) is Made Available in the Body When Administered as a Single SC Injection or as 2 SC Injections

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811999) titled 'Comparing the Extent to Which Romosozumab (AMG 785) is Made Available in the Body When Administered as a Single SC Injection or as 2 SC Injections' on Sept. 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: Amgen

Condition: Healthy Participants

Intervention: Drug: Romosozumab

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: September 22, 2026

Target Sample Size: 308

To know more, visit https://clinicaltrials.gov/study/NCT07811999

Published ...